EUVIMEDEUVIMED entdecken
Crossref

TUBB3 Is Associated With a Poor Prognosis and Basal Subtypes in Upper and Lower Tract Urothelial Carcinoma

Naofumi Nomura, Yohei Sekino iD, Tetsutaro Hayashi, Go Kobayashi, Hikaru Nakahara, Ryo Tasaka, Yuki Kohada, Kenshiro Takemoto, Miki Naito, Shunsuke Miyamoto, Kohei Kobatake iD, Hiroyuki Kitano und 6 weitere

International Journal of Urology · 2025-12 · 32 (12) · 1893-1901

DOI: 10.1111/iju.70220 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Urology, online erschienen am 14.09.2025. Verfasst von Naofumi Nomura und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan. Hauptthemen laut MEDLINE: Tubulin, Urinary Bladder Neoplasms, Biomarkers, Tumor, Carcinoma, Transitional Cell. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 30 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives β3‐tubulin, which is encoded by tubulin‐β3 ( TUBB3 ), is a microtubule protein. Although previous studies have indicated that TUBB3 overexpression is associated with a poor prognosis and chemoresistance in bladder cancer (BLCA), no studies have conducted comprehensive in silico analyses of urothelial carcinoma (UC) via public databases. We aimed to analyze the role of TUBB3 in UC via immunohistochemistry (IHC) and public database analysis.

Methods

We performed IHC and in silico analyses to investigate the clinicopathological significance of TUBB3 in UC, evaluated its role in determining the molecular subtype, and examined its impact on the effectiveness of chemotherapy, BCG treatment, and immunotherapy in patients with UC using public databases.

Results

IHC revealed that 18 of 71 (25.4%) BLCA cases were positive for β3‐tubulin. The β3‐tubulin‐positive group had a greater disease stage and poorer cancer‐specific survival (CSS). In silico analysis revealed that there was significant upregulation of TUBB3 expression in BLCA, particularly in muscle‐invasive bladder cancer (MIBC), relative to normal urothelium. High TUBB3 expression was associated with the basal molecular subtype and a poor prognosis. There was no association between the expression of TUBB3 and the efficacy of BCG therapy, cisplatin‐based chemotherapy, or immunotherapy. The high expression of TUBB3 was also associated with aggressive features, a poor prognosis, and the basal subtype of upper‐tract urothelial carcinoma (UTUC).

Conclusions

TUBB3 may play an essential role in the development and progression of UC. TUBB3 was associated with the basal subtype. TUBB3 could be a potential therapeutic target and biomarker in UC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TubulinUrinary Bladder NeoplasmsBiomarkers, TumorCarcinoma, Transitional CellHumansPrognosisMaleFemaleAgedMiddle AgedBCG VaccineImmunohistochemistryUrotheliumImmunotherapyAged, 80 and overUp-RegulationNeoplasm Staging

Stichwörter der Autor:innen

TUBB3bladder cancerchemotherapyimmunotherapymolecular subtypeurothelial carcinoma

Substanzen

TubulinTUBB3 protein, humanBCG VaccineBiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Urology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
  • Department of Urology, Matsuyama Red Cross Hospital, Ehime, Japan.
  • Laboratory of Molecular Pathology, Department of Molecular Biosciences, Radiation Effects Research Foundation, Hiroshima, Japan.
  • Department of Clinical and Molecular Genetics, Hiroshima University Hospital, Hiroshima, Japan.

ORCID-Profile: Yohei Sekino, Kohei Kobatake, Keisuke Goto, Nobuyuki Hinata

Zitieren

APA

Nomura, N., Sekino, Y., Hayashi, T., Kobayashi, G., Nakahara, H., Tasaka, R., Kohada, Y., Takemoto, K., Naito, M., Miyamoto, S., Kobatake, K., Kitano, H., Goto, K., Goriki, A., Hieda, K., Niitsu, H., Hinoi, T., & Hinata, N. (2025). TUBB3 Is Associated With a Poor Prognosis and Basal Subtypes in Upper and Lower Tract Urothelial Carcinoma. International Journal of Urology, 32(12), 1893-1901. https://doi.org/10.1111/iju.70220

Vancouver

Nomura N, Sekino Y, Hayashi T, Kobayashi G, Nakahara H, Tasaka R, et al. TUBB3 Is Associated With a Poor Prognosis and Basal Subtypes in Upper and Lower Tract Urothelial Carcinoma. International Journal of Urology. 2025;32(12):1893-1901. doi:10.1111/iju.70220

BibTeX
@article{Nomura2025,
  author = {Nomura, Naofumi and Sekino, Yohei and Hayashi, Tetsutaro and Kobayashi, Go and Nakahara, Hikaru and Tasaka, Ryo and Kohada, Yuki and Takemoto, Kenshiro and Naito, Miki and Miyamoto, Shunsuke and Kobatake, Kohei and Kitano, Hiroyuki and Goto, Keisuke and Goriki, Akihiro and Hieda, Keisuke and Niitsu, Hiroaki and Hinoi, Takao and Hinata, Nobuyuki},
  title = {TUBB3 Is Associated With a Poor Prognosis and Basal Subtypes in Upper and Lower Tract Urothelial Carcinoma},
  journal = {International Journal of Urology},
  year = {2025},
  volume = {32},
  number = {12},
  pages = {1893--1901},
  doi = {10.1111/iju.70220}
}
Kostenlos starten →